Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Relevance to major depression
While GLP-1s had mostly been prescribed for patients with type 2 diabetes as recently as two years ago (as of May 2024), the number of patients without a diabetes diagnosis using GLP-1s for weight loss has risen exponentially for example, they grew from 21K in 2019 to 174K in 2023, an increase of more than 700%
When looking at safety, most of the treatment-emergent adverse events (TEAEs) were mild to moderate in severity and gastrointestinal-related, according to the company
I accepted the poke but declined the drip
The comparison becomes even more stark when you consider the trajectory of weight loss over time
Knowing the difference between normal adjustment symptoms and red flags could be critically important
